CSTL NASDAQ
Castle Biosciences, Inc.
1W: -0.7%
1M: +6.4%
3M: +46.9%
YTD: -7.7%
1Y: +54.5%
3Y: +117.0%
5Y: -50.9%
$35.56
+0.30 (+0.87%)
Weekly Expected Move ±5.0%
$32
$34
$36
$37
$39
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships7
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-10-19
Earliest Filing
2022-04-04
Latest Filing
target: 3
partner: 2
supplier: 2
Counterparties (Filed by CSTL)
7 relationshipsCompanies named in CSTL's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| AltheaDx, Inc. | — | target | Target company in a merger agreement to be acquired by Castle Biosciences, Inc. | 2022-04-04 | View |
| Acorn Merger Sub, Inc. | — | partner | Merger subsidiary entity formed to facilitate the acquisition of AltheaDx, Inc. | 2022-04-04 | View |
| Alturas Siete I, LLC | — | partner | Landlord for the Fourth Amendment to Standard Office Lease | 2022-03-17 | View |
| Cernostics, Inc. | — | target | Target of acquisition via merger agreement amended on December 2, 2021. | 2021-12-06 | View |
| Alturas Siete II, LLC | — | supplier | Landlord for the 3707 office lease amendment | 2021-12-03 | View |
| Alturas Siete I, LLC | — | supplier | Landlord for the 3737 office lease amendment | 2021-12-03 | View |
| Cernostics, Inc. | — | target | Target company in a merger agreement where Castle Biosciences will acquire Cernostics. | 2021-10-19 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-07-30 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-05-29 | Shareholder Vote | View | |
| 2026-05-06 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-11-03 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-08-08 | Amendments to Articles of Incorporation or Bylaws | View | |
| 2025-08-04 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-05-23 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-05-05 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-02-27 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-01-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-11-04 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-08-05 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-05-24 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-05-02 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-03-27 | Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; | Agreement | View |
| 2024-02-28 | Results of Operations and Financial Condition; Regulation FD Disclosure | View | |
| 2024-01-08 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2023-11-09 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR